InVivo has signed an agreement through its holding company, InVivo AgroSciences, to acquire Bioline, a subsidiary of Syngenta specialized in the production and marketing of biological control agents, and in particular macroorganisms active against insect pests in fruits, vegetables, and flowers.
According to InVivo, by joining forces, Bioline and Biotop, a long-standing InVivo subsidiary working in biological pest control, will become a global player in a high-potential and fast-growing market.
Investing in high-potential businesses is one of the stated ambitions in the “2025 by InVivo” strategic plan. On the same level as digital agriculture, biosolutions are among the main future paths that the InVivo group intends to explore.
Strengthened by its subsidiary Biotop, the acquisition of Bioline will enable InVivo to build the capacities required to develop significant activity in biosolutions. The growth of this billion-dollar market is estimated at 10% a year for the coming 10 years.
Bioline is highly present in the macroorganisms market and more specifically in mites in northern Europe used against predatory insects in greenhouse crops. Biotop has a bioplant in the Drôme department in France, specializing in the production of ephestia eggs (used for raising auxiliaries) and trichogramma (micro-wasps that fight against corn borers).
“We are convinced that Bioline’s potential will be better realized in combination with InVivo, who are already well-positioned in this market,” says Alexander Tokarz, Head of Global Crops and Assets at Syngenta. “Syngenta remains fully committed to the broader field of biological solutions complementing our innovative crop protection and traits portfolio with enhanced spectrum and differentiated modes of actions.”